Bath & Body Works, Inc. (BMV:BBWI)
| Market Cap | 70.34B -11.6% |
| Revenue (ttm) | 135.24B -2.2% |
| Net Income | 13.95B +6.2% |
| EPS | 70.33 +11.3% |
| Shares Out | n/a |
| PE Ratio | 5.96 |
| Forward PE | 7.50 |
| Dividend | 14.11 (3.37%) |
| Ex-Dividend Date | Nov 20, 2026 |
| Volume | n/a |
| Open | 419.00 |
| Previous Close | 419.00 |
| Day's Range | 419.00 - 419.00 |
| 52-Week Range | 267.00 - 430.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 19, 2026 |
About Bath & Body Works
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the... [Read more]
Financial Performance
In fiscal year 2026, Bath & Body Works's revenue was $7.29 billion, a decrease of -0.22% compared to the previous year's $7.31 billion. Earnings were $649.00 million, a decrease of -18.67%.
Financial numbers in USD Financial StatementsNews
Bath & Body Works price target lowered to $20 from $24 at BMO Capital
BMO Capital analyst Kelly Crago lowered the firm’s price target on Bath & Body Works to $20 from $24 and keeps a Market Perform rating on the shares. The company’s…
Bath & Body Works price target lowered to $19 from $22 at UBS
UBS lowered the firm’s price target on Bath & Body Works to $19 from $22 and keeps a Neutral rating on the shares. The Q3 report looks like a small…
Bath & Body Works price target lowered to $23 from $24 at JPMorgan
JPMorgan analyst Matthew Boss lowered the firm’s price target on Bath & Body Works to $23 from $24 and keeps a Neutral rating on the shares.
Bath & Body Works price target lowered to $25 from $30 at BofA
BofA lowered the firm’s price target on Bath & Body Works to $25 from $30 and keeps a Buy rating on the shares. The firm is lowering its FY27 EPS…
Bath & Body Works price target lowered to $22 from $23 at Baird
Baird analyst Mark Altschwager lowered the firm’s price target on Bath & Body Works to $22 from $23 and keeps a Neutral rating on the shares. The firm updated its…
Bath & Body Works price target lowered to $21 from $22 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Bath & Body Works to $21 from $22 and keeps an Equal Weight rating on the shares. Q3 results reinforce the firm’s…
Bath & Body Works and Pantone Launch a Limited-Edition Fragrance Collection for the Holidays
What You Should Know A new collaboration between Bath & Body Works and Pantone blends trending colors with elevated fragrance in a limited-time collection for the holidays. Combining Bath & Body Wo...
Watch CNBC's full interview with Bath & Body Works CEO Daniel Heaf
CNBC's Sara Eisen sits down with Bath & Body Works CEO Daniel Heaf to discuss the company's Q3 earnings, holiday season expectations, consumer trends to turnaround plans.
Thursday's First Moves: WSM & BBWI Earnings, BE Upgrade & Price Target Cut
Diane King Hall covers the retail space with Williams-Sonoma (WSM) and its post-earnings plunge, along with Bath & Body Works (BBWI) and its beat. However, she notes a potentially challenging holiday ...
Bath & Body Works Earnings Call Transcript: Q3 2027
Q3 sales and adjusted EPS beat guidance as digital, new franchises and international growth gained traction. FY26 sales guidance improved, while holiday traffic, tariffs and uneven seasonal and store performance remain key pressures.
Bath & Body Works Earnings release: Q3 2027
Bath & Body Works released its Q3 2027 earnings on November 19, 2026, summarizing the period's financial results.
Bath & Body Works Slides: Q3 2027
Bath & Body Works has posted slides in relation to its Q3 2027 quarterly earnings report, which was published on November 19, 2026.
Bath & Body Works Quarterly report: Q3 2027
Bath & Body Works has published its Q3 2027 quarterly earnings report on November 19, 2026.
Bath & Body Works CEO Says Turnaround Progressing But Incomplete
The soaps and fragrances retailer made progress in the third quarter selling more online and through wholesale distributors, Chief Executive Daniel Heaf said in an interview.
Bath & Body Works reports Q3 adjusted EPS 26c, consensus 12c
Reports Q3 revenue $1.58B, consensus $1.55B. “Our product innovation is resonating with customers and digital delivered its second consecutive quarter of growth. Our wholesale business with Ulta and A...
Bath & Body Works backs FY26 adjusted EPS view $2.60-$2.80, consensus $2.71
Raises FY26 revenue growth view to (3.4%)-(2.1%) from (4%)-(2.5%), consensus $7.11B.
Bath & Body Works announces new $500M share repurchase program
Bath & Body Works announced that the Board of Directors approved a new share repurchase program authorizing the company to repurchase up to $500M of the company’s outstanding shares of…
Bath & Body Works sees Q4 diluted EPS $1.41-$1.61, consensus $1.72
For the fourth quarter of 2026, the company is forecasting net sales to decline between 5.5% and 2.0% compared to $2.724B in the fourth quarter of 2025. Published first on…
Bath & Body Works Reports Third Quarter Results Exceeding Guidance and Raises Full-Year Sales Outlook
Delivers Q3 net sales and adjusted earnings per share above guidance Third quarter net sales of $1.6 billion, down 1.0%. Earnings per diluted share of $0.19; adjusted earnings per diluted share of $0....
'BIGGEST MISTAKE': Top retail CEO reveals why rivals are COLLAPSING
Bath & Body Works CEO Daniel Heaf speaks to Fox News Digital about why 'staying still' is retail's biggest mistake, how every single store remains profitable and the brand's major store redesign.
Bath & Body Works price target raised to $22 from $20 at Morgan Stanley
Morgan Stanley analyst Alex Straton raised the firm’s price target on Bath & Body Works to $22 from $20 and keeps an Equal Weight rating on the shares. Published first…
Bath & Body Works price target raised to $22 from $17 at UBS
UBS analyst Jay Sole raised the firm’s price target on Bath & Body Works to $22 from $17 and keeps a Neutral rating on the shares. The firm sees a…
Bath & Body Works price target lowered to $24 from $25 at TD Cowen
TD Cowen lowered the firm’s price target on Bath & Body Works to $24 from $25 and keeps a Buy rating on the shares. The firm adjusted targets in the…
Bath & Body Works bets big on Middle America: CEO unveils major store revamp
Rather than chasing big-city flagships, Bath & Body Works is rolling out its new store concept in Middle America as CEO Daniel Heaf reveals every location is profitable.
Bath & Body Works Declares Cash Dividend
COLUMBUS, Ohio, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on December 4, 2026,...